Table 1.
Statistical results for the ceRNA networks across 15 anti-cancer drug categories
| MOA | miRNAs | lncRNAs | PCGs | Nodes | Edges |
|---|---|---|---|---|---|
| YK | 158 | 217 | 1,384 | 1,759 | 9,334 |
| Df | 149 | 213 | 1,044 | 1,406 | 4,661 |
| Ds | 157 | 217 | 1,369 | 1,743 | 8,831 |
| A7 | 158 | 217 | 1,379 | 1,754 | 9,241 |
| AM | 156 | 216 | 1,329 | 1,701 | 8,103 |
| Db | 151 | 211 | 1,073 | 1,435 | 5,299 |
| Ho | 158 | 217 | 1,380 | 1,755 | 9,085 |
| Rs | 146 | 209 | 1,140 | 1,495 | 4,423 |
| Tu | 155 | 217 | 1,346 | 1,718 | 8,167 |
| T2 | 154 | 216 | 1,290 | 1,660 | 7,890 |
| Apo | 151 | 212 | 1,108 | 1,471 | 6,015 |
| DNMT | 148 | 209 | 1,104 | 1,461 | 4,390 |
| STK | 150 | 213 | 1,220 | 1,583 | 5,731 |
| T1 | 152 | 209 | 1,049 | 1,410 | 4,597 |
| Pr | 145 | 210 | 1,078 | 1,433 | 4,302 |
MOA, mechanism of action.